Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028688 · ClinicalTrials.gov registry record · NA
HIFLO ENDO-High Flow Nasal Cannula in GI Endoscopy
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 262
- Enrollment target
NCT03028688 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 262 participants.
The verdict
NCT03028688, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
Study Summary
Millions of patients undergo upper GI endoscopy in the United States each year. A large number of these patients have anesthesia to assist with their comfort during the procedure. The majority of patients do not have a protected airway during the procedure, meaning there is no endotracheal tube. Instead the current standard of care is to give supplementary oxygen via nasal cannula. Because patients are deeply sedated or have general anesthesia there is a risk for low oxygen saturation during the procedure, which presents a significant patient safety issue. The purpose of the clinical trial is compare the current anesthesia standard of care against high flow nasal cannula oxygen delivery during anesthesia. The investigator's hypothesis is that high flow nasal cannula oxygen delivery will decrease the frequency with which patients experience hypoxemia during anesthesia for upper GI endoscopy.
Interventions
- DEVICE High flow nasal cannula oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2017-06-21 |
| Est. Completion | 2019-05-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03028688
The ClinicalTrials.gov registry entry for NCT03028688 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High flow nasal cannula oxygen is the first listed.
NCT03028688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03028688 about?
NCT03028688 is a clinical study titled "HIFLO ENDO-High Flow Nasal Cannula in GI Endoscopy". Millions of patients undergo upper GI endoscopy in the United States each year. A large number of these patients have anesthesia to assist with their comfort during the procedure. The majority of patients do not have a protected airway during the procedure, meaning there is no endotracheal tube. Ins...
What is the current status of trial NCT03028688?
This trial is currently completed. It is a NA study. The enrollment target is 262 participants. The study started on 2017-06-21. Estimated completion is 2019-05-09.
What interventions are being tested in trial NCT03028688?
The interventions under investigation include: High flow nasal cannula oxygen (DEVICE).
Who is sponsoring clinical trial NCT03028688?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.